Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Dental Implants Market
The global dental implants market was valued at USD 9.61 billion in 2025 and is projected to reach USD 19.81 billion by 2035, expanding at a CAGR of 7.5% over the forecast period. Growth is driven by rising edentulism rates, technological advancements in implant materials, and increasing adoption of digital dentistry workflows. The market remains concentrated among established multinational manufacturers, with limited penetration in emerging economies due to cost constraints.
Market size
Growth trajectory through 2035
Dental Implants Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2026
- [Thu, 13 Aug 2026]: Precedence Research reports the global dental implants market is projected to surge to USD 15.08 billion by 2035, citing rising demand for single-tooth implants and digital dentistry integration.
Emerging opportunities added
- Growth in Emerging Markets Rapid urbanization and rising disposable incomes in Asia-Pacific, Latin America, and the Middle East & Africa are creating new demand centers for dental implants. Localized manufacturing and partnerships with regional distributors can help capture this untapped potential.
- Development of Biodegradable and Smart Implants Research into biodegradable implant materials and smart implants with integrated sensors for monitoring osseointegration presents long-term growth opportunities. These innovations could reduce revision surgeries and improve patient outcomes.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $9.61 Bn
- CAGR
- 7.50%
- Expansion
- 2.1×
Market shape
top segment · 40.7% share
- Leading region
- North America
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Procedure Costs and Limited Insurance Coverage
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
[Thu, 13 Aug 2026]: Precedence Research reports the global dental implants market is projected to surge to USD 15.08 billion by 2035, citing rising demand for single-tooth implants and digital dentistry integration
Report scope
What this report answers
The specific decisions and questions covered in the 169-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Dental Implants Market today ($9.61 Bn base), and how fast will it grow at 7.5% CAGR through 2035?
- Which of Endosteal Implants, Subperiosteal Implants, Transosteal Implants and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Tooth Replacement, Prosthetic Support, Orthodontic Anchorage applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Dentsply Sirona, Align Technology, Envista Holdings and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Aging Population and Edentulism) and top restraints (led by High Procedure Costs and Limited Insurance Coverage), with quantified CAGR impact?
- What regulatory shifts and 1 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Aging Population and Edentulism The global rise in edentulism, driven by demographic aging and increased prevalence of periodontal disease, continues to expand the addressable market for dental implants. In developed economies, over 36 million individuals are fully edentulous, creating sustained demand for implant-supported prosthetics.
- Technological Advancements in Implant Materials Innovations in biocompatible materials, such as zirconium and ceramic implants, are improving osseointegration and patient outcomes. These materials offer enhanced durability and aesthetic compatibility, particularly for anterior restorations.
- Digital Dentistry and CAD/CAM Integration The adoption of digital workflows, including 3D imaging and computer-aided design/manufacturing (CAD/CAM), is streamlining implant procedures and reducing procedural complexity. This trend is lowering barriers to adoption among dental practitioners.
Restraints
Holding it back
- High Procedure Costs and Limited Insurance Coverage The upfront cost of dental implants remains a significant barrier for many patients, particularly in price-sensitive markets. Insufficient insurance reimbursement for implant procedures further constrains market expansion in lower-income regions.
- Regulatory and Compliance Challenges Stringent regulatory requirements for implant materials and manufacturing processes increase time-to-market for new products. Compliance with international standards, such as ISO and FDA guidelines, adds operational complexity for manufacturers.
- Competition from Alternative Restorative Solutions Traditional solutions, such as dentures and bridges, continue to dominate in cost-sensitive segments. While implants offer superior long-term outcomes, their higher initial cost limits adoption in price-sensitive markets.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging Population and Edentulism | +3.4% | Global | 2025–2035 |
| Technological Advancements in Implant Materials | +2.1% | Global | 2025–2035 |
| Digital Dentistry and CAD/CAM Integration | +1.7% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Procedure Costs and Limited Insurance Coverage | −1.4% | Global | 2025–2029 |
| Regulatory and Compliance Challenges | −0.9% | Global | 2025–2029 |
| Competition from Alternative Restorative Solutions | −0.7% | Global | 2025–2029 |
The dental implants market is segmented by product type, material, end-user, and region. Product segmentation includes endosteal, subperiosteal, transosteal, and intramucosal implants, while material segmentation covers titanium, zirconium, ceramic, and porcelain-fused-to-metal implants.
Revenue share by type · 2025 base year
% OF $9.61 BN DENTAL IMPLANTS MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $9.61 Bn Dental Implants Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Endosteal Implants
-
Subperiosteal Implants
-
Transosteal Implants
-
Intramucosal Implants
By application
-
Tooth Replacement
-
Prosthetic Support
-
Orthodontic Anchorage
-
Maxillofacial Reconstruction
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $9.61 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~45.9% in 2025. The region accounted for the largest market share in 2025, driven by high healthcare expenditure, advanced dental infrastructure, and strong demand for premium implant solutions
Per-region detail
-
North America
The region accounted for the largest market share in 2025, driven by high healthcare expenditure, advanced dental infrastructure, and strong demand for premium implant solutions
-
Europe
Europe remains a key market, with Germany and the UK leading in adoption of advanced implant technologies. Regulatory frameworks and reimbursement policies support market stability
-
Asia-Pacific
The Asia-Pacific region is projected to exhibit the highest growth rate, fueled by increasing dental tourism, rising middle-class populations, and expanding healthcare access in countries such as China and India
-
Latin America
Growth in Latin America is constrained by economic factors but supported by rising awareness of dental aesthetics and increasing investment in healthcare infrastructure
-
Middle East & Africa
The market in this region is nascent but growing, with demand concentrated in urban centers and driven by medical tourism and expatriate populations
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The dental implants market is moderately concentrated, with a mix of multinational corporations and specialized dental manufacturers competing for market share. Price competition and product differentiation are key strategic levers.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Dentsply Sirona
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Align Technology
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Envista Holdings
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Straumann Group
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Henry Schein Dental
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Patterson Dental
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
3M Oral Care
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Ivoclar Vivadent AG
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• What is the market size for the Dental Implants market?
The global dental implants market is anticipated to grow from USD 5.88 Billion in 2023 to USD 12.05 Billion by 2030, at a CAGR of 10.8% during the forecast period. -
• Which region is domaining in the Dental Implants market?
North America accounted for the largest market in the Dental Implants market. North America accounted for 37% market share of the global market value. -
• Who are the major key players in the Dental Implants market?
Danaher, Dentsply Sirona, Henry Schein, Inc., Zimmer Biomet, Bicon, LLC, Adin Global, Institut Straumann AG, Sweden & Martina S.p.A., BEGO GmbH & Co. KG, NEOBIOTECH, Neoss Limited, ProScan, Osstem, TOV Implant LTD, Cortex, KYOCERA Corporation, DENTIUM, Alpha-Bio Tec Ltd, GC Corp., DIO Implant Co. Ltd. -
• What is the latest trend in the Dental Implants market?
Technological Advancements: Continuous advancements in technology, such as the integration of 3D printing and CAD/CAM technologies, have enhanced precision in implant placement and customization, improving overall treatment outcomes.
The Dental Implants Market is projected to reach $19.81 Bn by 2035, up from $9.61 Bn in 2025 — a 7.50% CAGR equating to roughly 2.1× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.